International physician survey on management of FOP: a modified Delphi study

International physician survey on management of FOP: a modified Delphi study

Abstract Fibrodysplasia ossificans progressiva (FOP), a disabling disorder of progressive heterotopic ossification (HEO), is caused by heterozygous gain-of- function mutations in Activin receptor A, type I (ACVR1, also known as ALK2), a bone morphogenetic protein (BMP) type I receptor. Presently, sy...

Full description

Bibliographic Details
Main Authors: Maja Di Rocco, Genevieve Baujat, Marta Bertamino, Matthew Brown, Carmen L. De Cunto, Patricia L. R. Delai, Elisabeth M. W. Eekhoff, Nobuhiko Haga, Edward Hsiao, Richard Keen, Rolf Morhart, Robert J. Pignolo, Frederick S. Kaplan
Format: Article
Language:English
Published: BMC 2017-06-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Fibrodysplasia ossificans progressiva
ACVR1
Online Access:http://link.springer.com/article/10.1186/s13023-017-0659-4

Internet

http://link.springer.com/article/10.1186/s13023-017-0659-4

Similar Items